Cover Image

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yihao Liu, Wenjun Meng, Lu Pan, Haoling Zhang, Qinqin He
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Chemical Biology & Drug Design
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exploring the Effect of Gomisin A on Non‐Small Cell Lung Cancer With Network Pharmacology, Molecular Docking, In Vitro and In Vivo Assays
by: Mei Liu, et al.
Published: (2024)

Plumbagin Triggers STING Pathway Activation to Suppress Non‐Small Cell Lung Cancer Progression
by: Li‐Ping Kang, et al.
Published: (2025)

Rutecarpine Suppresses Non‐Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+ T Cells
by: Ze‐Bo Jiang, et al.
Published: (2025)

Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance
by: Neha Sharma, et al.
Published: (2024)

Curculigoside Induces Ferroptosis in Non‐Small Cell Lung Cancer Cells Through a Mechanism Involving Wilms' Tumor 1‐Associating Protein‐Mediated m6A Modification of GTP Cyclohydrolase 1
by: Lizheng Lv, et al.
Published: (2026)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
by: Vladislav Lobanov, et al.
Published: (2025)

δ‐Tocotrienol Potentiates Breast and Prostate Cancer Cells to Paclitaxel via Suppressing PD‐L1‐Mediated Cancer‐Promoting Signaling
by: Zhenou Sun, et al.
Published: (2025)

Targeting Cancer Cell Proliferation Using Piperazine‐Linked Quinolinequinones: Mechanism and Metabolic Profile
by: Ayse Mine Yilmaz, et al.
Published: (2025)

Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
by: Mohamed El Oirdi
Published: (2024)

Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments
by: Wu Tao, et al.
Published: (2024)

Correction to Plumbagin's Antiproliferative Mechanism in Human Cancer Cells: A Copper‐Dependent Cytotoxic Approach
Published: (2024)

Small Molecule Inhibitors Targeting Cdc2‐Like Kinase 4: Advances, Challenges, and Opportunities
by: Yu Jiang, et al.
Published: (2025)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
by: Nurul Alam Inayatsyah, et al.
Published: (2024)

Investigation of the Inhibitory Effects and Underlying Mechanisms of Vitexin Derivatives Targeting CDK1 in HCT Colorectal Cancer Cells
by: Ying Zhao, et al.
Published: (2026)

Biochemical and Structural Studies of Protein Tyrosine Phosphatase PTP‐PEST (PTPN12) in Search of Small Molecule Inhibitors
by: Delna Johnson, et al.
Published: (2025)

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases
by: Chung‐Ting Kuo, et al.
Published: (2026)

Network Pharmacology, Machine Learning, Molecular Docking, and Cell Experiments Reveal the Therapeutic Mechanism of Radix Rehmanniae Praeparata in Psoriasis In Vitro
by: Tingting Zhang, et al.
Published: (2026)

The Immuno‐Metabolic Crosstalk in Lung Squamous Cell Carcinoma: Prognostic Insights and Therapeutic Clues
by: Haoyuan Xue, et al.
Published: (2026)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
by: Shreetama Bandyopadhayaya, et al.
Published: (2025)

Discovery of Novel Oxadiazole‐Triazole Hybrids as Lung and Cervical Cancer Agents: Synthesis, Docking, Biological Evaluation, and SAR Studies
by: Venkatraman Hegde, et al.
Published: (2025)

Morusin Reverses Epithelial‐Mesenchymal Transition in Gallbladder Cancer Cells by Regulating STAT3/HIF‐1α Signaling
by: Lichao Ji, et al.
Published: (2025)

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
by: Yi‐Fan Zhang, et al.
Published: (2024)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
by: Gözde Sayar, et al.
Published: (2026)

Design, Synthesis, Molecular Docking, ADME ‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential BRAF V600E / WT Inhibitors
by: Ankit Kumar Singh, et al.
Published: (2025)

Spalt‐Like Transcription Factor 4 Mediates Fatty Acid Oxidation to Foster 5‐Fluorouracil Resistance in Gastric Cancer Cells
by: Yong Zhu, et al.
Published: (2025)

Emerging Roles of Osmium Complexes in Cancer Therapy, Their Mechanism of Action, Challenges and Future Perspectives
by: Eman M. Atiyah, et al.
Published: (2026)

A Naturally Derived Glycosylated Oleanolic Acid Derivative Suppresses NF‐κB Translocation and Induces Intrinsic Apoptosis in Lung Adenocarcinoma Cells
by: Sankar Pajaniradje, et al.
Published: (2025)

Chemoresistance and Immune Suppression in Gastric Cancer Are Driven by PPDPF Overexpression
by: Chenqiang Pan, et al.
Published: (2026)

The Molecular Mechanism of Resveratrol in the Treatment of Chronic Rhinosinusitis Through a Combination of Network Pharmacology and In Vitro Validation
by: Xiao Cheng, et al.
Published: (2025)

Mitotic Arrest Deficient 2 Like 1 Contributes to Colorectal Cancer Cell Migration, Invasion, and Oxaliplatin Resistance Through the Wnt/β‐Catenin Pathway
by: Xiang Ding, et al.
Published: (2024)

In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research
by: Behnaz Yazdani, et al.
Published: (2025)

Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells
by: Burak Kuzu, et al.
Published: (2025)

Molecular Mechanism of Dexmedetomidine in Alzheimer's Disease: Machine Learning Identifies RGS7 as a Key Therapeutic Targe
by: Yangliang Yang, et al.
Published: (2025)

Advances in the Molecular Mechanism of Kappa Opioid Receptors Signaling and the Important Sampling Methods to Probe the Activation Landscape of GPCRs
by: Mingqiong Tong, et al.
Published: (2025)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
by: Jingting Zeng, et al.
Published: (2025)

Polyphyllin VII Enhances the Sensitivity of Prostate Cancer Cells to Docetaxel by Promoting Mitochondrial Dysfunction and Inducing Ferroptosis
by: Yun‐Yi Chen, et al.
Published: (2025)

From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting LOXL2 in Breast Cancer
by: Sandra Ferreira, et al.
Published: (2026)

Novel Phenoxyacetic Acid (4‐Aminophenoacetic Acid) Shikonin Ester Kills KRAS Mutant Colon Cancer Cells via Targeting the Akt Allosteric Site
by: Yudi Ma, et al.
Published: (2025)

Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer
by: Jian Guo, et al.
Published: (2024)

Platinum‐Based Chemotherapeutics in the Modern Era: From Classical DNA ‐Targeting Mechanisms to Next‐Generation Innovations in Cancer Therapy
by: Mohammad Bagher Shahsavani, et al.
Published: (2025)